Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Natera Inc
(NQ:
NTRA
)
92.71
-0.17 (-0.18%)
Streaming Delayed Price
Updated: 12:59 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Natera Inc
< Previous
1
2
3
4
5
6
Next >
Natera to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejection
June 04, 2023
From
Natera, Inc.
Via
Business Wire
New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types
May 30, 2023
From
Natera, Inc.
Via
Business Wire
Jury Rules in Favor of Natera, Finding all Asserted Patents Valid and Infringed by ArcherDX/Invitae; Awards $19.35 Million in Past Damages for Royalties and Lost Profits
May 15, 2023
From
Natera, Inc.
Via
Business Wire
Natera Reports First Quarter 2023 Financial Results
May 09, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting
May 08, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces First Quarter 2023 Earnings Conference Call
May 02, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces New Signatera™ MRD Data at 2023 AACR Annual Meeting
April 14, 2023
From
Natera, Inc.
Via
Business Wire
New Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma
March 22, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Commercial Payor Coverage for Signatera™
March 02, 2023
From
Natera, Inc.
Via
Business Wire
Natera Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Participate in Upcoming Investor Conferences
February 24, 2023
From
Natera, Inc.
Via
Business Wire
Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors
February 23, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call
February 21, 2023
From
Natera, Inc.
Via
Business Wire
Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Breast Cancer
February 16, 2023
From
Natera, Inc.
Via
Business Wire
New Paper Highlights Clinical Utility of Natera’s Renasight™ Test in the Management of Kidney Disease
February 02, 2023
From
Natera, Inc.
Via
Business Wire
New Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023
January 19, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancer
January 17, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Webcast Live Presentation at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Natera, Inc.
Via
Business Wire
Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients
December 21, 2022
From
Natera, Inc.
Via
Business Wire
Is Illumina Still the Gamechanger in Genomics Sequencing?
October 04, 2022
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused
Via
MarketBeat
Topics
Earnings
Economy
Lawsuit
Exposures
Financial
Legal
Supply Chain
NASDAQ:NTRA Long Term Investor Notice: Investigation of Potential Wrongdoing at Natera, Inc.
September 02, 2022
San Diego, CA -- (SBWIRE) -- 09/02/2022 -- Certain directors of Natera, Inc are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Natera, Inc. (NTRA) Investors of Class Action and Encourages Investors to Actively Participate
June 27, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
NATERA 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Natera, Inc. - NTRA
June 24, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
NATERA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Natera, Inc. and Encourages Investors to Contact the Firm
June 24, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Natera, Inc. (NTRA)
June 24, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
NASDAQ:NTRA Investor Alert: Deadline on June 27, 2022 in Lawsuit Against Natera, Inc.
June 22, 2022
San Diego, CA -- (SBWIRE) -- 06/22/2022 -- The Shareholders Foundation announced that a deadline is coming up on June 27, 2022 in the lawsuit filed for certain investors of Natera, Inc. (NASDAQ:NTRA).
Via
SBWire
Tackling Recurring Health Conditions Offers Hope to Patients
June 21, 2022
Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly...
Via
FinancialNewsMedia
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Upcoming Lead Plaintiff Deadline
June 14, 2022
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
INVESTOR DEADLINE: Natera, Inc. Investors with Substantial Losses Have Opportunity to Lead Natera Class Action Lawsuit – NTRA
May 27, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.